pCR to Targeted Tx Before Sx = Better Survival for Early HER2+

Options
Moderators
Moderators Member Posts: 25,912

Pathologic Complete Response to Targeted Therapy Before Surgery Linked to Better Survival for Early-Stage HER2-Positive Breast Cancer
October 30, 2020

Women diagnosed with early-stage HER2-positive breast cancer treated with Herceptin and Tykerb before surgery who had a pathologic complete response (pCR) had better survival than women who didn't have a pCR. Read more...

Categories